MedPath

Parental cancer and the family: Screening for psychosocial risk in parents and their childre

Conditions
psychosociale gevolgen van kanker
family adjustment
psychosocial problems
Registration Number
NL-OMON56965
Lead Sponsor
OLVG
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

To be eligible to participate in this study, a participant must meet the
following criteria:
Patient
- The patient was newly diagnosed with cancer within the past 4 months
- The patient has at least one child aged 0 to 18 living at home
- The patient is receiving curative or palliative treatment, or this treatment
is planned
- The patient is at least 18 years old

Partners
- Partner of a patient who has been diagnosed with cancer and has at least one
child aged 0 to 18 living at home
- The partner lives with the patient
- The partner is at least 18 years old

Children (T2)
- The child has a parent who has been diagnosed with cancer
- The child is at least 8 and up to 18 years of age
- The child is living at home
Children with pre-existing psychosocial co-morbidity may participate in the
study; this is not an exclusion criterion.

Participation of members from the same family.
Not all family members have to be willing to participate in the study. At least
one of the parents (patient or partner) has to participate at T1. Thus,
children cannot participate if neither of their parents participates at T1.
However, a parent can participate if his/her partner does not want to
participate in the study.

Exclusion Criteria

A potential participant who meets any of the following criteria will be
excluded from participation in the study:
• Patients, partners or children who do not have sufficient proficiency of the
Dutch language to complete the questionnaires
• Ex-partners of patients who do not live with the patient
• Children (8-18 years old) of which neither of their parents participates at
T1.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath